Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly Halts Hanmi BTK Inhibitor Trial For RA, Mulls Other Indications

Feb 20 2018

• By Jung Won Shin

Render illustration of Clinical Trial title on medical documents

Related Content

Lilly Signs Major Collaboration With Hanmi For RA Drug

Mar 20 2015

Rolontis Leads Hanmi’s Global Ambitions As ADVANCE Phase III Endpoint Met

Feb 09 2018

Surprise Boehringer Decision Turns Hanmi Investors’ Hopes To Despair

Sep 30 2016

Related Companies

Eli Lilly and Company

Hanmi Pharmaceutical Co., Ltd.

Boehringer Ingelheim GmbH

Spectrum Pharmaceuticals, Inc.

Additional Topics

South Korea Asia Pacific US States Research & Development Clinical Trials BioPharmaceutical

More from R&D

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window